Does Fidaxomicin reduce Cure and Recurrence rates compared to Vancomycin in Clostridium Difficile Infection patients?: A Systematic Review and Meta-analysis. GAIMS Journal of Medical Sciences, v. 2, n. 1 (Jan-Jun), p. 30–35, 12 Jun.2022.